Get the Stockscreener App
10.11
2.79%
-0.29
After Hours:
10.23
0.12
+1.19%
Ginkgo Bioworks Holdings Inc Stock (DNA) Forecast
The Ginkgo Bioworks Holdings Inc (DNA) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $2.0117, representing a -80.10% decrease from the current price of $10.11. The highest analyst price target is $2.0188, and the lowest is $2.0046.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month DNA Price Target
Average 9.4168
(-6.86% Downside)
Is Ginkgo Bioworks Holdings Inc (DNA) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 64.50 | Neutral |
| STOCH(9,6) | 80.05 | Sell |
| STOCHRSI(14) | 91.96 | Sell |
| MACD(12,26) | 0.448 | Buy |
| ADX(14) | 29.97 | Buy |
| William %R | -24.50 | Neutral |
| CCI(14) | 109.98 | Buy |
Buy: 3
Sell: 2
Neutral: 2
Summary: Buy
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
9.557
Buy
|
9.6227
Buy
|
| MA20 |
8.909
Buy
|
9.2109
Buy
|
| MA50 |
8.7096
Buy
|
8.7158
Buy
|
| MA100 |
8.1202
Buy
|
8.6046
Buy
|
| MA200 |
9.3328
Buy
|
8.7858
Buy
|
Buy: 10
Sell: 0
Neutral: 0
Summary: Buy
According to our latest analysis, DNA could be considered a Strong Buy, with 17 technical analysis indicators signaling 13 Buy signals, 2 signaling Sell signals and 2 Neutral signals. This might be a good time to open fresh positions on DNA, as trading bullish markets is always a lot easier
- RSI (Relative Strength Index): The RSI(14) value of 64.5 indicates that DNA is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 80.05 indicates that DNA is oversold. This means that DNA price is at or near the highest level over a specified lookback period.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 91.96 indicates that DNA is oversold. This suggests that DNA price is at or near the highest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 29.97 suggests a moderate trend in the market. While not exceptionally strong, it indicates that there is some directional movement occurring. You should pay attention to this trend but may also look for confirmation from other technical indicators or fundamental factors.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of 109.98 indicates that DNA is overbought. This means that the price has moved significantly higher than its average, indicating a potential selling opportunity.
Long-term DNA price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Ginkgo Bioworks Holdings Inc financial reports and earnings history, Ginkgo Bioworks Holdings Inc (DNA) stock could reach $1.2136 by 2030, $43.64 by 2040 and $13.85 by 2050. See the projected annual prices until 2050 of the Ginkgo Bioworks Holdings Inc stock below:
- Ginkgo Bioworks Holdings Inc (DNA) is expected to reach an average price of $14.22 in 2035, with a high prediction of $15.76 and a low estimate of $14.27. This indicates an $40.68% rise from the last recorded price of $10.11.
- Ginkgo Bioworks Holdings Inc (DNA) stock is projected to chart a bullish course in 2040, with an average price target of $42.64, representing an $321.77% surge from its current level. The forecast ranges from a conservative $42.71 to a sky-high $43.64.
- Our analysts predict Ginkgo Bioworks Holdings Inc (DNA) to jump 709.49% by 2045, soaring from $82.41 to an average price of $81.84, potentially reaching $82.50. While $82.41 is the low estimate, the potential upside is significant.
- Ginkgo Bioworks Holdings Inc (DNA) stock is expected to climb by 2050, reaching an average of $11.96, a $18.33% jump from its current level. However, a wide range of estimates exists, with high and low targets of $13.85 and $12.00, respectively, highlighting the market's uncertainty.
Ginkgo Bioworks Holdings Inc Stock (DNA) Year by Year Forecast
Ginkgo Bioworks Holdings Inc Stock (DNA) Price Forecast for 2026
The predicted value for Ginkgo Bioworks Holdings Inc (DNA) in 2026 is set at an average of $2.5329. Estimates vary from a peak of $4.5993 to a trough of $0.4666, indicating an -74.95% surge from the present price of $10.11.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| August, 2026 | $1.9746 | $2.0046 | $2.0188 | -80.47% |
| September, 2026 | $1.484 | $1.564 | $1.5825 | -85.32% |
| October, 2026 | $0.9856 | $0.9477 | $1.0319 | -90.25% |
| November, 2026 | $0.9772 | $0.9772 | $1.0414 | -90.33% |
| December, 2026 | $0.2566 | $0.4666 | $0.825 | -97.46% |
Ginkgo Bioworks Holdings Inc Stock (DNA) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Ginkgo Bioworks Holdings Inc (DNA) is $9.7628, with a high forecast of $19.44 and a low forecast of $0.0827. This indicates an -3.43% decrease from the last price of $10.11.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $0.3782 | $0.4182 | $0.2945 | -96.26% |
| February, 2027 | $0.2548 | $0.209 | $0.166 | -97.48% |
| March, 2027 | $13.15 | $0.0827 | $11.48 | +30.08% |
| April, 2027 | $16.74 | $14.06 | $13.27 | +65.63% |
| May, 2027 | $16.43 | $14.61 | $14.66 | +62.49% |
| June, 2027 | $17.94 | $17.97 | $18.75 | +77.42% |
| July, 2027 | $18.85 | $18.20 | $18.58 | +86.45% |
| August, 2027 | $19.55 | $18.85 | $19.44 | +93.40% |
| September, 2027 | $17.94 | $18.16 | $18.64 | +77.47% |
| October, 2027 | $18.46 | $18.27 | $18.32 | +82.64% |
| November, 2027 | $16.81 | $17.61 | $18.12 | +66.25% |
| December, 2027 | $17.27 | $17.29 | $17.41 | +70.79% |
Ginkgo Bioworks Holdings Inc Stock (DNA) Price Forecast for 2028
In 2028, Ginkgo Bioworks Holdings Inc (DNA) is projected to reach an average price of $12.95, with a high projection of $16.08 and a low estimate of $9.8074. This indicates an +28.04% rise from the last price of $10.11.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $16.13 | $16.27 | $16.08 | +59.55% |
| February, 2028 | $15.55 | $15.71 | $15.67 | +53.84% |
| March, 2028 | $14.71 | $14.86 | $15.33 | +45.52% |
| April, 2028 | $14.29 | $14.17 | $14.03 | +41.30% |
| May, 2028 | $13.84 | $13.89 | $13.78 | +36.93% |
| June, 2028 | $13.56 | $13.71 | $13.71 | +34.10% |
| July, 2028 | $13.20 | $13.27 | $13.29 | +30.57% |
| August, 2028 | $11.84 | $12.04 | $12.66 | +17.10% |
| September, 2028 | $11.77 | $11.83 | $11.72 | +16.44% |
| October, 2028 | $11.32 | $11.40 | $11.60 | +11.92% |
| November, 2028 | $10.54 | $10.60 | $11.04 | +4.30% |
| December, 2028 | $9.5874 | $9.8074 | $10.28 | -5.17% |
Ginkgo Bioworks Holdings Inc Stock (DNA) Price Forecast for 2029
The 2029 price forecast for Ginkgo Bioworks Holdings Inc Stock (DNA) is $5.3455 on average, with a high prediction of $9.1532 and a low estimate of $1.5379. This represents an -47.13% decrease from the previous price of $10.11.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $8.5863 | $8.6255 | $9.1532 | -15.07% |
| February, 2029 | $7.2494 | $7.6044 | $8.2021 | -28.29% |
| March, 2029 | $7.1025 | $6.906 | $6.9252 | -29.75% |
| April, 2029 | $6.0656 | $6.0856 | $6.9483 | -40.00% |
| May, 2029 | $5.7745 | $5.9445 | $5.903 | -42.88% |
| June, 2029 | $5.4676 | $5.5376 | $5.4853 | -45.92% |
| July, 2029 | $4.7207 | $4.8207 | $4.9734 | -53.31% |
| August, 2029 | $3.6096 | $3.8096 | $4.4665 | -64.30% |
| September, 2029 | $3.4927 | $3.5412 | $3.3927 | -65.45% |
| October, 2029 | $2.4116 | $2.5416 | $3.1885 | -76.15% |
| November, 2029 | $2.0048 | $2.0948 | $2.2378 | -80.17% |
| December, 2029 | $1.4879 | $1.5379 | $1.8005 | -85.28% |
Ginkgo Bioworks Holdings Inc Stock (DNA) Price Forecast for 2030
Ginkgo Bioworks Holdings Inc Stock (DNA) is expected to reach an average price of $15.87 in 2030, with a high forecast of $30.79 and a low forecast of $0.9561. This signifies an +57.01% surge from the last price of $10.11.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $1.0848 | $0.9561 | $1.2136 | -89.27% |
| February, 2030 | $26.52 | $26.07 | $24.84 | +162.36% |
| March, 2030 | $26.43 | $27.04 | $27.28 | +161.42% |
| April, 2030 | $30.82 | $27.06 | $29.34 | +204.89% |
| May, 2030 | $29.94 | $30.08 | $30.79 | +196.17% |
| June, 2030 | $30.97 | $30.39 | $30.21 | +206.30% |
| July, 2030 | $28.97 | $29.22 | $30.74 | +186.50% |
| August, 2030 | $29.28 | $29.08 | $28.69 | +189.61% |
| September, 2030 | $27.98 | $28.70 | $28.89 | +176.80% |
| October, 2030 | $27.10 | $27.64 | $27.72 | +168.08% |
| November, 2030 | $25.97 | $26.14 | $26.94 | +156.90% |
| December, 2030 | $24.36 | $25.08 | $25.49 | +140.97% |
0.05%
0.74%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):